On November 19, 2024, the American Association for the Study of Liver Diseases (AASLD) came to an end. Eieling Technology Limited brought its star product, Liverscan liver health diagnostic system, to the 2024 Liver Meeting (TLM).
Eieling Technology Limited demonstrates to the world its outstanding innovation and solid technology in the field of liver disease detection.
Liverscan
As a diagnostic device that integrates wireless connection, dual mode and high flexibility, Liverscan successfully integrates the Transient Elastography Imaging (TE) and Ultrasonic real-time imaging guide B, and while adopting a composite probe design, it has achieved a significant reduction in cost, with a reduction of up to 50%. It is the most ideal solution for liver fibrosis screening, which can effectively lower the threshold for treatment and control the risk of liver disease.
During the exhibition, Liverscan not only became the focus of everyone’s attention, but also received high attention and positive comments from all parties.
Afterwards,Eieling Technology Limited demonstrated the operation process of Liverscan and invited customers to experience Liverscan in person, which was highly praised by customers. Liverscan not only has a simple and intuitive interface design, convenient operation, excellent portability, but also generates reports quickly, which improves clinical testing efficiency while providing healthcare providers with an accurate and reliable liver health diagnosis tool.
The appearance of Liverscan at the AASLD is an important demonstration of Eieling Technology’s technological innovation and product development in the medical industry. In the future, Liverscan will be widely used in various scenarios, benefiting medical institutions at all levels. We look forward to meeting you again at future events and witnessing more innovations and developments in the field of liver health from Eieling Technology.
